Structural chromosomal variations in neurological diseases

B. Kálmán, Emilia Vitale

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

BACKGROUND: Significant advancement in the identification of genetic mutations and molecular pathways underlying Mendelian neurologic disorders was accomplished by using the methods of linkage, gene cloning, sequencing, mutation, and functional analyses, in the 1990s. Subsequently, the Human Genome Project defined the entire sequence of the genome providing reference for any pathologic condition, and identified single nucleotide polymorphisms as a means for whole genome association studies and linkage disequilibrium mapping in common, complex trait diseases. Simultaneously, data also emerged describing the structural chromosomal variations, and it became increasingly recognized that in addition to the more traditional mutation types, gene copy number variations (CNVs) contribute to normal variability in human phenotypes and may underlie the development of diseases with Mendelian inheritance, complex trait, or sporadic presentation. REVIEW SUMMARY: Here we describe the occurrence of CNVs in the human genome, and discuss their importance in health and disease. Targeting the practicing neurologist, we review the presently known CNVs with pathogenic significance in common neurologic disorders, and highlight new research directions in complex trait diseases. CONCLUSIONS: The role of chromosomal structural variations in the pathogenesis of neurologic disorders is increasingly recognized. Available data may only capture a small subgroup of conditions related to these recently discovered genetic variations. The ongoing genome studies are expected to reveal structural chromosomal alterations as an underlying cause of many as yet poorly understood common diseases. New challenges include defining chromosomal break points, evaluating biologic consequences of gene dosage effect, and using molecular genetics for personalized therapeutic intervention. This survey of the CNV literature was closed in September 2008.

Original languageEnglish
Pages (from-to)245-253
Number of pages9
JournalNeurologist
Volume15
Issue number5
DOIs
Publication statusPublished - Sep 2009

Fingerprint

Nervous System Diseases
Gene Dosage
Mutation
Molecular Biology
Genome
Human Genome Project
Chromosome Breakage
Chromosome Mapping
Genome-Wide Association Study
Linkage Disequilibrium
Human Genome
Single Nucleotide Polymorphism
Organism Cloning
Phenotype
Health
Research
Genes
Therapeutics

Keywords

  • Copy number variations
  • Genetic variations
  • Neurologic disorders

ASJC Scopus subject areas

  • Clinical Neurology

Cite this

Structural chromosomal variations in neurological diseases. / Kálmán, B.; Vitale, Emilia.

In: Neurologist, Vol. 15, No. 5, 09.2009, p. 245-253.

Research output: Contribution to journalArticle

Kálmán, B. ; Vitale, Emilia. / Structural chromosomal variations in neurological diseases. In: Neurologist. 2009 ; Vol. 15, No. 5. pp. 245-253.
@article{b68224ed32404dbcb23b5ec8d68aeb59,
title = "Structural chromosomal variations in neurological diseases",
abstract = "BACKGROUND: Significant advancement in the identification of genetic mutations and molecular pathways underlying Mendelian neurologic disorders was accomplished by using the methods of linkage, gene cloning, sequencing, mutation, and functional analyses, in the 1990s. Subsequently, the Human Genome Project defined the entire sequence of the genome providing reference for any pathologic condition, and identified single nucleotide polymorphisms as a means for whole genome association studies and linkage disequilibrium mapping in common, complex trait diseases. Simultaneously, data also emerged describing the structural chromosomal variations, and it became increasingly recognized that in addition to the more traditional mutation types, gene copy number variations (CNVs) contribute to normal variability in human phenotypes and may underlie the development of diseases with Mendelian inheritance, complex trait, or sporadic presentation. REVIEW SUMMARY: Here we describe the occurrence of CNVs in the human genome, and discuss their importance in health and disease. Targeting the practicing neurologist, we review the presently known CNVs with pathogenic significance in common neurologic disorders, and highlight new research directions in complex trait diseases. CONCLUSIONS: The role of chromosomal structural variations in the pathogenesis of neurologic disorders is increasingly recognized. Available data may only capture a small subgroup of conditions related to these recently discovered genetic variations. The ongoing genome studies are expected to reveal structural chromosomal alterations as an underlying cause of many as yet poorly understood common diseases. New challenges include defining chromosomal break points, evaluating biologic consequences of gene dosage effect, and using molecular genetics for personalized therapeutic intervention. This survey of the CNV literature was closed in September 2008.",
keywords = "Copy number variations, Genetic variations, Neurologic disorders",
author = "B. K{\'a}lm{\'a}n and Emilia Vitale",
year = "2009",
month = "9",
doi = "10.1097/NRL.0b013e3181963cef",
language = "English",
volume = "15",
pages = "245--253",
journal = "Neurologist",
issn = "1074-7931",
publisher = "Lippincott Williams and Wilkins",
number = "5",

}

TY - JOUR

T1 - Structural chromosomal variations in neurological diseases

AU - Kálmán, B.

AU - Vitale, Emilia

PY - 2009/9

Y1 - 2009/9

N2 - BACKGROUND: Significant advancement in the identification of genetic mutations and molecular pathways underlying Mendelian neurologic disorders was accomplished by using the methods of linkage, gene cloning, sequencing, mutation, and functional analyses, in the 1990s. Subsequently, the Human Genome Project defined the entire sequence of the genome providing reference for any pathologic condition, and identified single nucleotide polymorphisms as a means for whole genome association studies and linkage disequilibrium mapping in common, complex trait diseases. Simultaneously, data also emerged describing the structural chromosomal variations, and it became increasingly recognized that in addition to the more traditional mutation types, gene copy number variations (CNVs) contribute to normal variability in human phenotypes and may underlie the development of diseases with Mendelian inheritance, complex trait, or sporadic presentation. REVIEW SUMMARY: Here we describe the occurrence of CNVs in the human genome, and discuss their importance in health and disease. Targeting the practicing neurologist, we review the presently known CNVs with pathogenic significance in common neurologic disorders, and highlight new research directions in complex trait diseases. CONCLUSIONS: The role of chromosomal structural variations in the pathogenesis of neurologic disorders is increasingly recognized. Available data may only capture a small subgroup of conditions related to these recently discovered genetic variations. The ongoing genome studies are expected to reveal structural chromosomal alterations as an underlying cause of many as yet poorly understood common diseases. New challenges include defining chromosomal break points, evaluating biologic consequences of gene dosage effect, and using molecular genetics for personalized therapeutic intervention. This survey of the CNV literature was closed in September 2008.

AB - BACKGROUND: Significant advancement in the identification of genetic mutations and molecular pathways underlying Mendelian neurologic disorders was accomplished by using the methods of linkage, gene cloning, sequencing, mutation, and functional analyses, in the 1990s. Subsequently, the Human Genome Project defined the entire sequence of the genome providing reference for any pathologic condition, and identified single nucleotide polymorphisms as a means for whole genome association studies and linkage disequilibrium mapping in common, complex trait diseases. Simultaneously, data also emerged describing the structural chromosomal variations, and it became increasingly recognized that in addition to the more traditional mutation types, gene copy number variations (CNVs) contribute to normal variability in human phenotypes and may underlie the development of diseases with Mendelian inheritance, complex trait, or sporadic presentation. REVIEW SUMMARY: Here we describe the occurrence of CNVs in the human genome, and discuss their importance in health and disease. Targeting the practicing neurologist, we review the presently known CNVs with pathogenic significance in common neurologic disorders, and highlight new research directions in complex trait diseases. CONCLUSIONS: The role of chromosomal structural variations in the pathogenesis of neurologic disorders is increasingly recognized. Available data may only capture a small subgroup of conditions related to these recently discovered genetic variations. The ongoing genome studies are expected to reveal structural chromosomal alterations as an underlying cause of many as yet poorly understood common diseases. New challenges include defining chromosomal break points, evaluating biologic consequences of gene dosage effect, and using molecular genetics for personalized therapeutic intervention. This survey of the CNV literature was closed in September 2008.

KW - Copy number variations

KW - Genetic variations

KW - Neurologic disorders

UR - http://www.scopus.com/inward/record.url?scp=70349739657&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=70349739657&partnerID=8YFLogxK

U2 - 10.1097/NRL.0b013e3181963cef

DO - 10.1097/NRL.0b013e3181963cef

M3 - Article

C2 - 19741431

AN - SCOPUS:70349739657

VL - 15

SP - 245

EP - 253

JO - Neurologist

JF - Neurologist

SN - 1074-7931

IS - 5

ER -